INTRODUCTION
Mitogen-activated protein (MAP) kinases are serine/threoninespecific protein kinases that are regulated by dual phosphorylation on tyrosine and threonine residues (Ray and Sturgill, 1988) . Because dual phosphorylation is required for enzymic activation, it was initially suggested that MAP kinases may play a role in the integration of signals from distinct tyrosine-and serine/threonine-specific protein kinases (Anderson et al., 1990 ).
The MAP kinases are activated during Go transitions in cells stimulated to divide Posada et al., 1991; Kahan et al., 1992; L'Allemain et al., 1992) , to differentiate (Gotoh et al., 1990; Casillas et al., 1991) or to express certain differentiated functions (Ely et al., 1990; Casillas et al., 1991) , and they are also activated following stimulation of oocyte maturation (Ferrell et al., 1991; Posada et al., 1991) . Several members of the MAP kinase protein family have been identified, including p42 apl (extracellular signal-regulated protein kinase; ERK2) , p44rapk (ERKI) (Boulton et al., 1990) and a 54 kDa MAP-kinase-related protein (Kyriakis and Avruch, 1990) , as well as a possible splice variant of p42mapk (Gonzalez et al., 1992) . It is not yet known how or if these isoforms differ in function or regulation.
The mechanisms of activation of MAP kinases have been the subject of intense recent investigation. p42mapk has been shown to be capable ofa slow autophosphorylation on the site ofregulatory tyrosine phosphorylation (Tyr-185 in p42rapk) raising the possibility that there might exist in cells factors which could regulate this autophosphorylation activity ('autokinase enhancing factors') Seger et al., 1991; Ahn et al., 1991; Robbins and Cobb, 1992) . Evidence has also been presented that the tyrosine kinase p561ck can directly phosphorylate this site (Ettehadieh et al., 1992) . However, most recent work has concentrated on the identification (Gomez and Cohen, 1991 ; Adams and Parker, 1992; Alessandrini et al., 1992; Shirakabe et altered in the sites of regulatory phosphorylation to show, both in vivo and in vitro, that phosphorylation of the tyrosine and the threonine can occur independently of one another, with no required order of phosphorylation. We also utilized kinasedefective variants of MAP kinase with mutations in either the ATP-binding loop or the catalytic loop, and obtained data suggesting that the activity or structure of the catalytic loop of MAP kinase plays an important role in its own dual phosphorylation. al., 1992; Kosako et al., 1992) , purification Seger et al., 1992; Matsuda et al., 1992; Wu et al., 1992) and cloning Seger et al., 1992; Ashworth et al., 1992; Wu et al., 1993) of MAP kinase kinases (MAPKKs; mekl). MAPKKs appear to be dual-specificity protein kinases, capable of phosphorylating both the regulatory threonine and tyrosine residues, and hence enzymically activating p42malk and p44mavk in vitro.
Dual-specificity kinases are a recently described class ofprotein kinases. In the original classification by Hanks et al. (1988) , protein kinases fell into either the serine/threonine-specific class or the tyrosine-specific class, and could be distinguished on the basis of primary amino acid sequence motifs in kinase subdomains VI and VIII. Screening of cDNA expression libraries with anti-phosphotyrosine antibodies led to the discovery of protein kinases which could autophosphorylate on tyrosine, but which functioned as serine/threonine-specific protein kinases on exogenous substrates. Such so-called dual-specificity kinases include Clk, Mikl and Spkl (Lindberg et al., 1992) . It is not at all clear whether these kinases truly are dual specificity for exogenous substrates and whether their tyrosine autokinase activity has biological significance. MAP kinase is a dualspecificity kinase in this sense. The cell cycle regulator weel has been suggested to be a dual-specificity protein kinase because its mammalian substrate, cdc2, is (similarly to MAP kinase) regulated by dual phosphorylation on adjacent tyrosine and threonine residues. Weel can autophosphorylate on serine, threonine and tyrosine, but recently it has been shown that a human weel can phosphorylate cdc2 only on tyrosine (Parker and PiwnicaWorms, 1992 sites of regulatory phosphorylation, we found that phosphorylation of MAP kinase on tyrosine and threonine residues does not require a specific order of phosphorylation. This result was obtained in vitro with purified enzymes and in vivo in cells expressing the mutant MAP kinases, suggesting that the MAPKK which has been purified and cloned can account for the in vivo activation of MAP kinase. In addition, we have examined the possible role of MAP kinase autophosphorylation in the dual specificity of MAPKK, and present evidence suggesting that the ability of MAP kinase to catalyse phosphate transfer plays a role in its threonine phosphorylation by MAPKK.
MATERIALS AND METHODS Materials
The oligonucleotide encoding the epitope was purchased from Operon (Alameda, CA, U.S.A.). The nucleotide sequence is 5'-TTGGATCCTACCCATATGATGTTCCAGATTACGCT GGATCCATGGCC-3'. Dulbecco's modified Eagle's medium (DMEM) and G418 neomycin were obtained from Gibco, and [32P]P1 and [y-32P]ATP (6000 Ci/mmol) were from Du Pont-New England Nuclear (Boston, MA, U.S.A.).
Epitope tagging of MAP kinases and expression
Epitope tagging was done by insertion of an oligonucleotide encoding a peptide GLGSYPYDVPDYAGSM containing an epitope (shown in bold) described before (Field et al., 1988) at the N-terminal side of Gly-8 of wild-type and mutant MAP kinases (T183A, Y185F, T183A/Y185F, T183F, T183E, Y185E, T183E/Y185E and K52R, where the first letter indicates the amino acid at the residue number indicated in the wild-type protein, and the second letter indicates the amino acid present at that position in the mutant protein). For expression in CCL39 hamster fibroblasts, the tagged MAP kinases were subcloned into expression vector pLNCAL7 under the control of the cytomegalovirus promoter. Transfections were performed using Lipofectin (BRL Life Technologies, Inc., Gaithersburg, MD, U.S.A.) and 10,g of DNAs according to the protocol provided by the company. Cells expressing the tagged MAP kinase proteins were selected by growth in DMEM supplemented with 5 % calf serum plus 5 % fetal calf serum containing 500 #g/ml neomycin.
G418-resistant clones were screened for expression of the tagged proteins by Western blotting of cell lysates from each clone with culture supernatant containing monoclonal antibody 12CA5, which is specific for the epitope. Clones with the highest expression levels of each tagged mutant were used for the in vivo 32P labelling experiment described.
In vivo 2P labeiiing of MAP kinase
For in vivo 32p labelling, cells were grown in 60-mm plates to 90% confluence in selection medium before starting labeffing.
To start labelling, cells were depleted of serum by replacing the medium with 2 ml of phosphate-free DMEM supplemented with 5 % normal serum-free medium, and were labelled by adding [32P]P1 (2.5 mCi/ml) to each plate at the same time. After 6 h. cells were stimulated with 10% fetal calf serum for 10 min, washed twice with ice-cold phosphate-buffered saline, lysed in 0.4 ml Nonidet P-40 lysis buffer (1 % Nonidet P-40,150 nM NaCl, 10 mM Tris, pH 8.0, 1 mM phenylmethanesulphonyl fluoride, 0.4 mM EDTA, 10 mM NaFI, 2 4ug/ml aprotinin, 2,g/ml leupeptin, 10 mM N-nitrophenyl phosphate) and the lysates were cleared by centrifugation at 14000 rev./min for 10 min.
immunoprecipitatlon of the tagged proteins The tagged proteins from 0.4 ml of the cleared lysates were immunoprecipitated with 10 1 of monoclonal antibody 12CA5 ascites (BABCO, Berkeley, CA, U.S.A.) at 4°C for 2 h on a rotating shaker. A 200,g portion of rabbit anti-mouse IgG (Jackson Laboratories, Bar Harbor, ME, U.S.A.) preincubated with 100,u of 50% Protein A-Sepharose beads (Pharmacia, Piscataway, NJ, U.S.A.) was added to each immunoprecipitation reaction at the same time. The immunocomplexes were washed twice with 0.8 ml of the lysis buffer and twice with 0.8 ml of Trisbuffered saline, resuspended in 60,u of2 x electrophoresis sample buffer and boiled for 5 min. The immunoprecipitated proteins were resolved by SDS/PAGE, transferred to Immobilon (Millipore, Bedford, MA, U.S.A.) and exposed to film. Antiphosphotyrosine Western blotting was done essentially as described (L'Allemain et al., 1992) . After the primary antibody reaction, the signal was detected using horseradish peroxidaselinked goat anti-rabbit IgG and developed with enhanced chemiluminescence Western blotting detection reagents (Amersham, Arlington Heights, IL, U.S.A.). For anti-epitope blotting, the filter was stripped, blocked in phosphate-buffered saline containing 5% dry milk and reprobed with the 12CA5 culture supernatant. Horseradish peroxidase-linked sheep anti-mouse IgG was used to detect the signals. Blotting of MAP kinase was performed with the monoclonal antibody IB3B9, raised in this laboratory against p42 MAP kinase, and sold by Upstate Biotechnology (Lake Placid, NY, U.S.A.).
Immunocompiex MBP kinase assay
For each reaction, 20#1d of rabbit anti-(MAP kinase) antiserum (TR2) was preincubated with 200,1 of 50 % Protein A-Sepharose beads for I h on ice. The beads were washed once with Trisbuffered saline then added to 0.4 ml of whole-cell lysate at 4°C for 2 h. The immunocomplexes were washed twice in the lysis buffer, twice in Tris-buffered saline and once in a final wash buffer (20 mM Hepes, pH 7.8, 10 mM magnesium acetate). The beads were resuspended in 100 of the final wash buffer and a 30 #1 portion was used for the assay. The kinase reaction was performed as described before .
PurMicaton of MAPKK
MAPKK was purified essentially as described in Wu et al. (1992) . Rabbit muscle (500 g) was homogenized in buffer containing 2 mM EDTA, 2 mM EGTA, 25 mM NaF, 1 mM sodium pyrophosphate, 1 mM sodium vanadate, 1 mM benzamidine, 0.1 % fl-mercaptoethanol and 1 mM phenylmethanesulphonyl fluoride at pH 7.0. The homogenate was centrifuged and the supernatant was subjected to batch adsorption in 250 ml of DE52 equilibrated in homogenization buffer containing 25 mM Tris, pH 7.0, at 4 'C. The flow-through was collected, adjusted to pH 8.8 and applied to Fast Flow Q equilibrated with the same homogenization buffer at pH 8.8. The resin was washed with 25 mM NaCl plus the homogenization buffer and eluted with 300 mM NaCl in the homogenization buffer. The NaCl concentration of the eluate was brought up to 1 M and it was adsorbed to phenyl-Sepharose. The phenyl-Sepharose was washed with the same buffer without NaCl and eluted with 60 % 2 mM sodium vanadate, 10 mM sodium pyrophosphate, ethylene glycol. The eluate was then diluted and applied to Mono Mechanisms for phosphorylation of mitogen-activated protein kinase Q at pH 8.8. The fractions containing MAPKK activity were pooled, dialysed and further purified sequentially by a second Mono Q column at pH 7.5, gel filtration, and finally through Superose 12.
In vitro MAPKK reacton A 3 ,ug sample of the purified recombinant MAP kinase proteins was used in each reaction. The reactions were started by adding 25 ,1l of 1.6 x 'hot ATP mix' [final concentrations: 10 mM magnesium acetate, 1 mM dithiothreitol, 50 mM f8-glycerol phosphate, 1 mM EDTA, 85 ,uM sodium vanadate, 100 #uM ATP (25 c.p.m./fmol) and 6 ,1 of the MAPKK purified from rabbit muscle cells ] to the recombinant substrates at 30°C for 1.5 h. To stop the reactions, 40 ,u of 2 x electrophoresis sample buffer was added to each tube and the mixtures were boiled for 5 min. Samples of 75,1 were loaded on to a 10% polyacrylamide gel. Phosphorylated proteins were transferred to Immobilon and exposed to Kodak X-AR film for 45 min. The bands corresponding to the MAP kinase proteins were excised from the filter for phosphoamino acid analysis (L'Allemain et al., 1992) .
Autophosphorylatlon of the kinase-defective mutants
Equal amounts of the recombinant K52R and D147A proteins (based on Bradford protein assays and staining of acrylamide gels) were used for the autokinase reactions. The specific radioactivity of ATP was constant (40 c.p.m./fmol) in every reaction, with concentrations of unlabelled ATP of 1O,uM, 50 lM, 100 #M, 1.0 mM or 1.7 mM in a final volume of 45 #1. Reactions were performed at 37°C for 1.5 h (which is within the linear range), and were stopped by addition of 12.5 ,ul of 4 x electrophoresis sample buffer followed by boiling for 5 min.
RESULTS

In vivo phosphorylatlon of MAP kinase
Phosphorylation on threonine-183 and tyrosine-185 are both necessary and sufficient to activate p42 MAP kinase in vivo (Ray and Sturgill, 1988; Anderson et al., 1990; Payne et al., 1991) and in vitro L'Allemain et al., 1992; Nakielny et al., 1992; Wu et al., 1992) . To determine whether the regulatory phosphorylation of these residues occurs independently or interdependently, a cDNA clone of murine p42 MAP kinase was mutagenized (L'Allemain et al., 1992) to alter the sites of regulatory phosphorylation either singly (T183E and Y185E) or in combination (TE/YE) to a charged nonphosphorylatable amino acid. In addition, a kinase-defective mutant was generated in which Lys-52, which is a conserved lysine in the ATP-binding loop (Knighton et al., 1991) and is believed to interact with the a-phosphate of ATP (Zheng et al., 1993) , was changed to Arg (K52R). The wild-type and mutant proteins were expressed in hamster fibroblasts under the control of the cytomegalovirus promoter.
To separate the exogenous mutants from endogenous MAP kinase, an epitope derived from influenza virus haemagglutinin (Field et al., 1988) To determine whether Try-185 is indeed the only tyrosine residue involved in MAP kinase activation, the proteins blotted on to Immobilon were probed with an anti-phosphotyrosine antibody (Figure lb ). The data demonstrate that mutation of Tyr-185 eliminates reactivity with an antibody against phosphotyrosine; only wild-type MAP kinase and mutants K52R and T183E reacted with the antibody, but Y185E and TE/YE (in which Tyr-185 is mutated) did not.
In a control kinase assay, endogenous p42 MAP kinase from each transfected cell culture clone was immunoprecipitated and shown to display serum-stimulated myelin basic protein (MBP) kinase activity ( Figure Ic, lower panel) . This result rules out the possibility that failure of TE/YE phosphorylation might be due to a failed response of the cells to serum. These data also demonstrate that none of these exogenously expressed mutants inhibits substantial activation of endogenous MAP kinase, i.e. none of them functions as a dominant negative mutant at the expression levels obtained in this system.
To find out if insertion of the epitope might affect MAP kinase activation, an immunocomplex MBP kinase assay was performed using the 12CA5 monoclonal antibody ( Figure Ic, upper panel) . The result shows that the tagged wild-type MAP kinase still possesses a regulatable kinase activity in response to serum. Interestingly, the data also show that all of the mutant MAP kinase proteins lack detectable kinase activity. Thus not only is the K52R mutant, which is defective in ATP binding, also defective in kinase activity, but the replacement of a phosphorylatable amino acid with glutamate is not able to substitute for a regulatory phosphorylation. This is the case even when only a single regulatory phosphorylation site is replaced by glutamate and the other site becomes phosphorylated in response to serum. Taken together, the data suggest that phosphorylation of both Thr-183 and Tyr-185 is required and sufficient for p42 MAP kinase activation.
The presence of MAP kinases in the immunocomplexes was confirmed by stripping the same blot and then reprobing with anti-(MAP kinase) antibody (Figure ld) . Therefore lack of phosphorylation of the TE/YE mutant (Figure la) and the absence of kinase activity (Figure ic, upper panel) 
Phosphorylation of MAP kinase in vitro
A MAPKK (mekl) has been purified and cloned in several laboratories Ashworth et al., 1992; Seger et al., 1992; Wu et al., 1993) . To determine whether the enzymic properties of this protein are consistent with the characteristics of the in vivo phosphorylation and activation of MAP kinase described above, we analysed the phosphorylation of MAP kinase mutants using purified MAPKK in vitro. The MAP kinase mutants were expressed in bacteria and purified to homogeneity (L'Allemain et al., 1992), and a MAPKK partially purified from rabbit muscle was used to phosphorylate the recombinant proteins. The result shown in Figure 2 (a) is consistent with the in vivo data, in that MAPKK can phosphorylate either Thr-183 or the Tyr-185 independently. Furthermore, no other sites of phosphorylation were detected in the double mutants TE/YE or T183A/Y185F. Note that mutants T183A and T183E seem to be better substrates than Y185F and Y185E respectively. We also found the same preference for tyrosine phosphorylation on MAP kinase when using whole-cell lysate as a source of MAPKK (L'Allemain et al., 1992) . Whether this is an intrinsic property of MAPKK and reflects the order of Tyr/Thr phosphorylation Haystead et al., 1992) or is due to structural characteristics of the purified recombinant substrate proteins is not yet clear.
The D147A mutant has a substitution of alanine for the aspartate in kinase subdomain VI (D'47LKPSN). This aspartate residue is believed to be the catalytic base (Knighton et al., 1991; Zheng et al., 1993) and lies in the catalytic loop (Hanks et al., 1988) . It is interesting to note that there is less phosphate incorporated into D147A than into the K52R mutant, raising the possibility that an intact catalytic subdomain of MAP kinase may be required for its full phosphorylation by MAPKK (see the Discussion section). This is further supported by the finding that heat denaturation of MAP kinase destroys its ability to function as a substrate for MAPKK (Figure 2b ). In addition, a synthetic peptide corresponding to the tryptic peptide containing the MAP kinase phosphorylation site does not serve as a substrate for the purified MAPKK (results not shown).
Phosphoamino acid analysis of MAP kinase mutants phosphorylated in vitro To determine which amino acids were phosphorylated by the MAPKK, phosphoamino acid analysis was performed with the mutant proteins from the above in vitro kinase assays. As expected, the wild-type MAP kinase (WT) was phosphorylated on both threonine and tyrosine residues (Figure 3a) . Mutants T183A and T183E, with Tyr-185 the only available acceptor, were phosphorylated on tyrosine only. Mutants Y185F and Y185E were phosphorylated only on threonine. The kinasedefective K52R mutant was phosphorylated on both tyrosine and threonine (Figure 3b) , consistent with the idea that MAPKK is a dual-specificity protein kinase. However, there was strikingly less phosphorylation on threonine in the case of the D147A mutant, which is predicted to be defective in catalytic properties. The data shown here, along with that from Figures 2(a) and 2(b BWT, wild-type MAP kinase which has been boiled for 10 min before the reactions; KR and DA as in (a). Robbins and Cobb, 1992) , and this reaction has been characterized as being intramolecular, based on concentration independence . To determine whether the autophosphorylation is inter-or intra-molecular using an independent rationale, we investigated whether excess kinase-defective MAP kinase could inhibit the autophosphorylation reaction (as would be expected if it were intermolecular). The autophosphorylation of purified, recombinant, epitope-tagged, wild-type MAP kinase was measured in the presence of increasing amounts of recombinant K52R mutant. The 1.7 kDa epitope allowed separation of the tagged wild-type protein from the untagged kinase-defective mutant. No inhibition of the wild-type autophosphorylation reaction was observed, even when K52R was present in 20-fold 
ATP-concentration-dependent K52R autophosphorylation
At high concentrations of mutant K52R, a small amount of phosphorylation of the kinase-defective protein was detected. To determine whether this mutant protein retained residual autokinase activity, the purified recombinant K52R was incubated with increasing amounts of[y-32P]ATP, and the reaction products were then separated by gel electrophoresis. As shown in Figure  5 , wild-type MAP kinase showed substantial autokinase activity within the range of ATP concentrations tested. The K52R mutant displayed low but detectable autokinase activity at ATP concentrations higher than 100 ,uM. The autokinase activity of the D147A mutant was below the level of detection under these conditions. Thus the mutant of MAP kinase that is kinasedefective because of a lesion in the ATP-binding domain could still display detectable autokinase activity at high ATP concentrations, whereas the mutant which is kinase-defective because of a lesion in the catalytic base has a lower autokinase capability. (Gomez and Cohen, 1991; L'Allemain et al., 1992; Nakielny et al., 1992; . The predicted amino acid sequence of MAPKK, based on the cloned cDNAs, is most similar to that of serine/threoninespecific protein kinases rather than tyrosine-specific protein kinases Ashworth et al., 1992; Wu et al., 1993) . Nevertheless, this enzyme is capable of catalysing the dual phosphorylation of MAP kinase on both threonine and tyrosine. In fact, the enzyme favours tyrosine phosphorylation kinetically , as the tyrosine phosphorylation of the MAP kinase substrate can go nearly to completion before substantial threonine phosphorylation is detected. Thus MAPKK functions as a 'dual-specificity' protein kinase on an exogenous substrate. Other protein kinases have been suggested to be dual-specificity kinases, e.g. MAP kinases, STYI/clk and SPK1 (reviewed in Lindberg et al., 1992) . These so-called dual-specificity kinases are capable of autophosphorylating on serine/threonine and on tyrosine, but phosphorylate exogenous substrates only on serine/threonine or on tyrosine. Weel has been thought to be a dual-specificity protein kinase because yeast plO7wedl is capable of autophosphorylation on serine and tyrosine , and the human cdc2 is phosphorylated on Thr-14 and Tyr-15. However recent evidence indicates that the human Weel kinase autophosphorylates and phosphorylates cdc2 only on tyrosine . Therefore Weel appears to be a tyrosine-specific protein kinase. Thus no kinase besides MAPKK has been shown to be able directly to phosphorylate an exogenous substrate on both serine/threonine and tyrosine. L'Allemain et al., 1992; Adams and Parker, 1992; Haystead et al., 1992) .
Although these results are suggestive of the notion that the MAP kinase catalytic domain participates in its own phosphorylation (especially on threonine), it is equally possible that the mutation we have introduced into the MAP kinase catalytic domain alters its structure so that it is poorly recognized by the MAPKK. Another possibility is that Tyr-185 is exposed in MAP kinase, but that 
